Archive for 2008/02


Kamada To Start Phase II Clinical Studies Of The Aerosolized Form Of AAT For The Treatment Of Bronchiectasis

Kamada (TASE:KMDA), a biopharmaceutical company which develops, manufactures and markets specialty life-saving therapeutics, announces that the company will soon start phase II clinical trials with the inhaled version of its Alpha-1 Antitrypsin (AAT) product to treat Bronchiectasis, a lung disease that results in the distortion of one or more of the conducting bronchi or airways, most often secondary to an infectious process.
(more...)


ACAAI Publishes New Supplement On Hereditary Angioedema

The American College of Allergy, Asthma & Immunology (ACAAI) has published for the first time a special supplement to its medical journal, Annals of Allergy, Asthma and Immunology, titled "Hereditary Angioedema: A Current State-of-the-Art Review." The nearly 50 page publication sheds new light on this often misunderstood disease.
(more...)


First-Of-Its-Kind Research Identifies Possible Target For Prevention And Treatment Of Pneumonia

Researchers at Children's Hospital of Pittsburgh of UPMC have identified a key protein target that may be a crucial factor in the development of a vaccine to prevent and new therapies to treat pneumonia, the leading killer of children worldwide.Research led by Jay K.
(more...)


One-Year Results Of Bronchial Thermoplasty In Refractory Asthma

Asthmatx, Inc., a medical device company that has developed a catheter-based procedure under investigation for the treatment of asthma, announced the publication of data from the Research in Severe Asthma (RISA) Trial of bronchial thermoplasty in the American Journal of Respiratory and Critical Care Medicine (AJRCCM, 2007; 176:1185-1191).
(more...)


Researchers At Pulmonary Associates To Study Airway Bypass Procedure For Severe Emphysema

Researchers at Pulmonary Associates announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a new, minimally invasive option for those suffering with advanced widespread emphysema.
(more...)


2008 Is A Decisive Year For The Validation Of The Asthma Target Interleukin-13

The Business Intelligence firm La Merie S.L. reported that during the year 2008 results of major phase II studies in asthma with two different interleukin-13 antagonistic antibodies are expected which will be decisive for the validation of a hot target. Interleukin-13 is regarded to have a central in the development of allergic asthma, mediating airway inflammation, obstruction and hyper-reactivity.
(more...)


Acupuncture And Success Of IVF

"Acupuncture can increase the chances of getting pregnant for women undergoing fertility treatment by 65%," according to The Guardian's news pages.The Times, The Daily Telegraph and BBC News covered the story and quoted Edward Ernst, a professor of complementary medicine, who cautioned that the effect might be due to a placebo effect caused by the women expecting acupuncture to work.
(more...)


Giving Mice A Cold Virus Offers Hope Of New Asthma Treatments

Scientists have been able to recreate rhinovirus infection, which is behind most common colds, in a small animal for the first time. For fifty years since they were discovered, it had been thought that rhinoviruses could only infect humans and chimpanzees. But now a team of scientists led by Professor Sebastian Johnston at the MRC/Asthma UK Centre in Allergic Mechanisms of Asthma at Imperial College London, has been able to infect mice with rhinoviruses.
(more...)


Environmental Tobacco Smoke Linked To Death Of Asthmatic Woman

A young asthmatic woman who collapsed and died shortly after arriving for her shift as a waitress at a bar may be the first reported death nationally from acute asthma associated with environmental tobacco smoke.
(more...)


Study Of Lung Disease Suggests New Therapy For Patients

A new study by researchers at Northwestern University's Feinberg School of Medicine may change current thinking about how best to treat patients in respiratory distress in hospital intensive care units.It has been commonly believed that high levels of carbon dioxide (CO2) or hypercapnia in the blood and lungs of patients with acute lung disease may be beneficial to them. Now, for the first time, scientists have shown how elevated levels of CO2 actually have the opposite effect.
(more...)